Cholangiocarcinoma (CCA) is a tumor with increasing prevalence around the world. The
prevalence of CCA is highest in East Asia and most significantly in the countries through …

Background Cholangiocarcinoma (CCA) is a relatively rare cancer worldwide; however, its
incidence is extremely high in Asia. Numerous studies reported that serum carbohydrate …

The digestive system cancers are leading cause of cancer‐related death worldwide, and
have high risks of morbidity and mortality. More and more long non‐coding RNA s (lnc RNA …

Background This study aimed to investigate the mi R‐192 levels in patients' sera of liver
fluke‐associated cholangiocarcinoma (CCA) for a prospective prognostic indicator. Methods …

Cholangiocarcinoma (CCA) is a unique liver cancer subtype with an increasing incidence
globally. The lack of specific symptoms and definite diagnostic markers results in a delayed …

Objective To evaluate the predictive value of multiple serum tumor markers in hepatolithiasis
complicated with intrahepatic cholangiocarcinoma (hepatolithiasis-associated …

Intrahepatic cholangiocarcinoma (ICC) is characterised by heterogeneity, and it can be
subdivided into small‐duct and large‐duct types. Inflammatory and tumour markers could …

Cholangiocellular carcinoma is the most frequent malignant neoplasm originating from the
epithelium of intra-or extrahepatic bile ducts. In the past decades, the incidence of …

Potential biomarkers which include S100 calcium binding protein A9 (S100A9), mucin 5AC
(MUC5AC), transforming growth factor β1 (TGF-β1), and angiopoietin-2 have previously …

Objective Cholangiocarcinoma (CCA) is usually fatal because of the absence of tests for
early detection and lack of effective therapy. Tumor markers with adequate diagnostic values …